Hepatocellular Carcinoma (HCC)

Hepatocellular carcinoma, or hepatoma, is a primary cancer of the liver. According to the 2005 edition of Cancer, Principles & Practice of Oncology, there are approximately one million new cases of hepatoma worldwide each year and, according to an article published in the Journal of Hepatology in 2004, hepatoma kills approximately one million people worldwide each year. A Phase III trial of Litx in patients with hepatoma is underway. The trial involves approximately 200 patients at sites in Singapore, Hong Kong, China, South Korea, the Philippines, Malaysia, Thailand, India, and certain European countries.